Virios Therapeutics Shares Are Trading Higher After the Company Announced the Publication of an International Patent Titled "Valacyclovir and Celecoxib for the Treatment of Alzheimer's and COVID-19"
Virios Therapeutics宣佈公佈一項名爲 “用於治療阿爾茨海默氏症和COVID-19的伐昔洛韋和塞來昔布” 的國際專利後，該公司股價走高